2014
DOI: 10.1521/aeap.2014.26.3.202
|View full text |Cite
|
Sign up to set email alerts
|

Barriers to Legal and Human Rights in Australia in the Era of HIV Treatment as Prevention

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2015
2015
2019
2019

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(8 citation statements)
references
References 21 publications
0
8
0
Order By: Relevance
“…There is little disagreement among HIV advocates, clinicians, medical and social scientists that TasP is clinically effective, but there is much debate about its population‐level effectiveness, its ‘real‐world’ implementation, and its political and ethical implications for people with HIV (e.g. Cameron and Godwin , Cohen et al . , Knight et al .…”
Section: Tasp and Biomedicalisationmentioning
confidence: 99%
See 1 more Smart Citation
“…There is little disagreement among HIV advocates, clinicians, medical and social scientists that TasP is clinically effective, but there is much debate about its population‐level effectiveness, its ‘real‐world’ implementation, and its political and ethical implications for people with HIV (e.g. Cameron and Godwin , Cohen et al . , Knight et al .…”
Section: Tasp and Biomedicalisationmentioning
confidence: 99%
“…There is little disagreement among HIV advocates, clinicians, medical and social scientists that TasP is clinically effective, but there is much debate about its population-level effectiveness, its 'real-world' implementation, and its political and ethical implications for people with HIV (e.g. Cameron and Godwin 2014, Cohen et al 2012, Knight et al 2014, Wilson 2012. There are also concerns that the use of HIV drugs for the dual purpose of health and prevention represents a troubling 'remedicalisation' of HIV that disregards its social complexities (Nguyen et al 2011), signalling an increasingly neoliberal response to the epidemic driven by technical expediency and market rationalities (Ingram 2013).…”
Section: Tasp and Biomedicalisationmentioning
confidence: 99%
“…As the social and political contexts of the 1970s and 1980s shaped Australia's early community response to HIV/AIDS, so, too, policy has adapted and evolved in line with social, epidemiological, political, medical and generational changes over the past four decades. Reflecting these changes, we identify three distinct policy periods: 1982-95, which saw the early response of partnerships and prevention; 1996-2009, a period of 'new hope, disinvestment and political neglect' (Brown et al 2014: 37); and 2010 to the present, a time of targets and biomedicine (Newman et al 2010;Brown et al 2014;Cameron and Godwin 2014). The objectives and policy measures adopted during these eras demonstrate the temporal success of Australia's HIV policy and its ability to reflect the changing nature of the epidemic and evolve with emerging evidence and evaluation of national strategies and interventions.…”
Section: Designing Implementing and Delivering A National Response Tmentioning
confidence: 99%
“…There are, however, growing concerns among some activists and researchers that the rush to end the epidemic will override the hard‐won human rights and justice‐based response to HIV championed by affected communities in Australia and elsewhere by putting increasing moral pressure on people to do their duty and act responsibly for the greater good, thereby undermining their right to autonomy, dignity, and freedom from discrimination (Barr et al. ; Cameron and Godwin ; Clayton et al. ).…”
Section: New Margins: Concluding Reflectionsmentioning
confidence: 99%